This inventor holds 1 USPTO granted patent. Top assignee: Yung Shin Pharm. Ind. Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Ming-Ching Cheng
Introduction
Ming-Ching Cheng is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of taxoids. His innovative work has led to the filing of a patent that showcases his expertise and creativity in chemical processes.
Latest Patents
Ming-Ching Cheng holds a patent for a process for preparing taxoids from baccatin derivatives using a Lewis acid catalyst. The patent describes a method of preparing a taxoid by reacting a protected baccatin derivative with a β-lactam in the presence of one or more Lewis acids and a base agent. Additionally, the invention outlines a process for preparing the protected baccatin derivative from a baccatin derivative, which involves a protection reaction catalyzed by Lewis acids with an optional base agent. This patent highlights his innovative approach to enhancing the synthesis of important pharmaceutical compounds.
Career Highlights
Ming-Ching Cheng is associated with Yung Shin Pharmaceutical Industrial Co., Ltd., where he applies his knowledge and skills in the pharmaceutical industry. His work at the company has allowed him to contribute to the development of new and effective medications. With a focus on innovation, he continues to push the boundaries of what is possible in his field.
Collaborations
Ming-Ching Cheng has collaborated with talented individuals such as Liang-Rern Kung and Shih-Sheng Chang. These collaborations have fostered a creative environment that encourages the exchange of ideas and the advancement of research in pharmaceutical sciences.
Conclusion
Ming-Ching Cheng's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts demonstrate his commitment to advancing medical science. His work not only enhances the understanding of taxoid preparation but also paves the way for future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile